Curium Acquires Zevacor Molecular Strengthening Its PET Portfolio

Curium and DMH Worldwide have closed a transaction in which Curium has acquired Zevacor Molecular. Zevacor Molecular is a leader in the production of Strontium-82, which is used in the production of Rubidium-82 generators for cardiac PET imaging. Rubidium-82 is the most frequently used cardiac positron emission tomography (PET) imaging agent in the U.S. The Zevacor Molecular business will be rebranded under the Curium name.

Read the full article: Curium Acquires Zevacor Molecular Strengthening Its PET Portfolio //

Source: http://www.globenewswire.com/news-release/2020/03/03/1994076/0/en/Curium-Acquires-Zevacor-Molecular-Strengthening-Its-PET-Portfolio.html

Scroll to Top